Breathe Well Live Well
NDTV |
Salt Room Therapy Beneficial In Asthma Treatment: Doctors
NDTV Agreed, Anju Chandra, founder of Salt Room Therapy, and said: "Salt room therapy is a drug-free treatment for asthma, chronic bronchitis, sinusitis, allergic and skin ailments. I am hopeful that this initiative will not just help people with … |
View full post on asthma – Google News
|
Salt room therapy beneficial in asthma treatment: Doctors
Times of India Agreed, Anju Chandra, founder of Salt Room Therapy, and said: "Salt room therapy is a drug-free treatment for asthma, chronic bronchitis, sinusitis, allergic and skin ailments. I am hopeful that this initiative will not just help people with … |
View full post on asthma – Google News
Deccan Chronicle |
Inhalation therapy is the best for treating asthma in children, doctors say
Times of India Addressing a press conference in Chennai on Wednesday ahead of the World Asthma Day, Dr Balasubramanian dispelled the myth that inhalation is too strong and should be used only as the last resort. "Inhalation medicines do contain steroids, but not the … Inhalation therapy, a key to win big against asthma World Asthma Day observed |
View full post on asthma – Google News
Zee News |
Inhalation therapy, a key to win big against asthma
Zee News New Delhi: When we think of Asthma, we picture a sneezing or a wheezing individual who seems to be perpetually ill. But is this the case every time? Often we try to run away from the harsh reality of the disease and ignore it, making the situation worst. |
View full post on asthma – Google News
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone furoate 100 mcg + Umeclidinium 62.5 mcg+Vilanterol 25 mcg; Drug: Fluticasone furoate 100 mcg + Vilanterol 25 mcg; Drug: Umeclidinium 62.5 mcg; Device: Placebo ELLIPTA inahler; Drug: Albuterol/Salbutamol
Sponsor: GlaxoSmithKline
Not yet recruiting – verified April 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Device: Positive Expiratory Pressure
Sponsor: University of Vermont
Not yet recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: olodaterol hydrochloride 2.5mcg, tiotropium bromide 2.5mcg; Drug: olodaterol 2.5 mcg
Sponsor: University of Dundee
Not yet recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Can Probiotic Therapy Prevent Asthma?
AAP News The children being tested were enrolled through the Canadian Healthy Infant Longitudinal Development (CHILD) Study, which has a goal to identify genetic and environmental causes of allergy and asthma. The nested case control study examined the … |
View full post on asthma – Google News
Proactive Investors USA & Canada |
BUZZ-Vectura: all-time high on completing asthma therapy trial
Reuters … ** Vectura up over 5 pct to all-time high & top FTSE 250 mid-cap gainer after it completes a clinical trial for generic asthma therapy VR315 in the U.S., bringing it closer to a commercial launch. ** Drug developer also reveals that its partner for … Drug developer Vectura on a high as asthma treatment completes US clinical trial Vectura Group Completes Clinical Trial For VR315 Asthma Treatment Vectura Completes Clinical Trial For VR315 In US; Stock Up |
View full post on asthma – Google News
PMLiVE |
GSK's severe asthma therapy Nucala gets EU nod
PMLiVE GlaxoSmithKline's first-in-class interleukin-5 (IL-5) inhibitor Nucala has been approved in the EU as a steroid-sparing therapy for patients with severe asthma. Nucala (mepolizumab) has been cleared by the European Commission as an add-on treatment for … |
View full post on asthma – Google News